Appendix B

Involving the U.S. Public and Private Sectors in the CVI

October 25–26, 1994

Wayside Inn

Middletown, VA

FINAL AGENDA

Day 1

7:30

Continental Breakfast

8:00

Welcome and Introductions

Samuel Katz, Steering Committee Member

8:05

The Children’s Vaccine Initiative: Status and Outlook

Ciro de Quadros, Workshop Co-Chair

8:30

The New UNICEF Procurement Strategy

John Gilmartin, UNICEF

9:00

Ensuring Vaccine Sufficiency in the Developing World

Peter Ndumbe, University of Yaounde, Cameroon (did not attend)



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 Appendix B Involving the U.S. Public and Private Sectors in the CVI October 25–26, 1994 Wayside Inn Middletown, VA FINAL AGENDA Day 1 7:30 Continental Breakfast 8:00 Welcome and Introductions Samuel Katz, Steering Committee Member 8:05 The Children’s Vaccine Initiative: Status and Outlook Ciro de Quadros, Workshop Co-Chair 8:30 The New UNICEF Procurement Strategy John Gilmartin, UNICEF 9:00 Ensuring Vaccine Sufficiency in the Developing World Peter Ndumbe, University of Yaounde, Cameroon (did not attend)

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 9:15 Discussion 10:00 Break 10:15 Why Greater U.S. Involvement in the CVI is a Good Idea Roy Widdus, National Vaccine Program Office 10:30 Combination Vaccines: Point of Entry to Developing-World Vaccine Markets Gordon Douglas, Workshop Co-Chair 10:45 Differential Pricing: A History and Look to the Future William Hubbard, Steering Committee Member Tim Westmoreland, U.S. Congress 11:15 Discussion 12:00 Lunch and Free Time 3:00 BREAK-OUT GROUPS CONVENE 5:00 Break 5:15 BREAK-OUT GROUPS REPORT 6:15 General Discussion 7:15 Adjourn 8:00 Workshop Dinner (at the Wayside Inn) Involving the U.S. Public and Private Sectors in the CVI Day 2 7:00 Continental Breakfast 7:30 Nonvaccine Technology Transfer: Case Studies Contraceptives: Jeff Spieler, USAID Agriculture and Animal Vaccines: Judith Chambers, USAID

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 8:00 Joint Ventures Between Developed- and Developing-Country Vaccine Makers Dennis Stainer, Stainer Associates 8:15 A Model for Technology Transfer to the Developing World George Siber, Massachusetts Department of Health 8:30 Discussion 9:30 Break 9:45 BREAK-OUT GROUPS CONVENE 11:00 Break 11:15 BREAK-OUT GROUPS REPORT 12:00 General Discussion 1:00 Closing Comments Caroline Hall, Steering Committee Chair 1:15 Adjournment and Lunch WORKSHOP SPEAKERS Judith Chambers, Ph.D., Biotechnology Specialist, Office of Agriculture and Food Security, Agency for International Development, Washington, DC Ciro de Quadros, M.D., M.P.H. (Steering Committee Member), Senior Advisor on Immunization, Pan American Health Organization, Washington, DC R. Gordon Douglas, Jr., M.D. (Steering Committee Member), President, Merck Vaccine Division, Whitehouse Station, NJ John Gilmartin, Chief, Purchasing, EPI, UNICEF Supply Division, Copenhagen, Denmark Caroline Breese Hall, M.D. (Steering Committee Chair), Professor of Pediatrics and Medicine in Infectious Disease, University of Rochester, School of Medicine and Dentistry, Rochester, NY William N. Hubbard, Jr., M.D. (Steering Committee Member), Hickory Corners, MI Samuel L. Katz, M.D. (Steering Committee Member), Wilburt C. Davison Professor, Department of Pediatrics, Duke University Medical Center, Durham, NC

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 George Siber, M.D., Director, Biologics Laboratory, Massachusetts Department of Health, Jamaica Plain, MA Jeff Spieler, Chief, Research Division, Office of Population, Agency for International Development, Washington, DC Dennis W. Stainer, President, Stainer Associates, Ontario, Canada Timothy M. Westmoreland Esq., Majority Counsel, Subcommittee on Health and the Environment, House Energy and Commerce Committee, Washington, DC Roy Widdus, Ph.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD COMMISSIONED PAPER “Technology Transfer: Lessons Learned—Vaccines, Contraceptives, and Plants” by Richard T. Mahoney, Ph.D., Vice President and Senior Advisor, Office of the President, Program for Appropriate Technology in Health, Seattle, WA WORKSHOP PARTICIPANTS Luis A.V. Barreto, M.D., Assistant Vice President, Clinical and Medical Affairs, Connaught Laboratories, Ltd., Ontario, Canada Francis R. Cano, Ph.D., President, Aviron, Burlingame, CA Jose F. Cordero, M.D., M.P.H., Deputy Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA Peter Evans, Acting Chief, Vaccine Supply and Quality, Global Programme on Vaccines, World Health Organization, Geneva, Switzerland Lance Gordon, Ph.D., President and Chief Executive Officer, ORAVAX Inc., Cambridge, MA William Hausdorff, Ph.D., Project Officer, Children’s Vaccine Initiative Project, Agency for International Development, Office of Health and Nutrition, Washington, DC Donald A. Henderson, M.D., M.P.H., Senior Science Advisor, Office of the Assistant Secretary for Health, U.S. Public Health Service, Baltimore, MD Wayne Morges, Ph.D., Vice President Manufacturing Operations, Amvax Inc., Beltsville, MD Robert C. Myers, D.V.M., Chief, Division of Biologic Products, Michigan Department of Public Health, Lansing, MI William Packer, President, Virus Research Institute Inc., Cambridge, MA Peter Paradiso, Ph.D., Senior Director of Scientific Affairs, Lederle-Praxis Biologicals, West Henrietta, NY

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 Regina Rabinovich, M.D., Assistant Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD Jerald C. Sadoff, M.D., Director, Division of Communicable Diseases and Immunology, Walter Reed Army Institute for Research, Washington, DC Tom Stagnaro, President and Chief Executive Officer, UNIVAX Biologics Inc., Rockville, MD Beatriz Zurita, London School of Hygiene and Tropical Medicine, University of London, London, England Staff Michael Stoto, Director, Division of Health Promotion and Disease Prevention Kathleen Stratton, Senior Program Officer Polly Harrison, Program Officer Greg Pearson, Program Officer Dee Sutton, Administrative Assistant

OCR for page 49
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994 This page in the original is blank.